a Department of Nanobiotechnology , Razi University , Kermanshah , Iran.
b Basic Science Research Professor (UGC), Department of Biotechnology , SGB Amravati University , Amravati , India.
Expert Rev Anti Infect Ther. 2019 Jun;17(6):419-428. doi: 10.1080/14787210.2019.1614914. Epub 2019 May 17.
: In recent years, multidrug resistance (MDR) in bacteria has drastically increased and has posed a great threat to the human health. This problem has generated an urgent need to search alternatives for the treatment of MDR bacteria. It has been proved that metal nanoparticles (MNPs) and metal nanocomposites (MNCs) possess remarkable antimicrobial potential, and hence can be used in alternative therapy. : This review is aimed to discuss recent reports on antibacterial activities of MNPs and MNCs against MDR bacteria. : , and are important pathogenic bacteria which have shown MDR against a wide range of conventional antibiotics. In this context, effects of MNPs and MNCs on these pathogens have demonstrated considerable efficacy. Several mechanisms concerning activity of MNPs and MNCs against pathogenic bacteria which are mainly dependent on type of their precursors and treated bacterium have been investigated. In addition, many studies have been made on antibacterial activities of these nanomaterials with similar and different results.
近年来,细菌的多药耐药性(MDR)急剧增加,对人类健康构成了极大威胁。这个问题迫切需要寻找治疗 MDR 细菌的替代方法。已经证明,金属纳米粒子(MNPs)和金属纳米复合材料(MNCs)具有显著的抗菌潜力,因此可以用于替代治疗。
本综述旨在讨论最近关于 MNPs 和 MNCs 对 MDR 细菌的抗菌活性的报道。金黄色葡萄球菌、铜绿假单胞菌和鲍曼不动杆菌是重要的致病菌,它们对多种常规抗生素表现出 MDR。在这方面,MNPs 和 MNCs 对这些病原体的作用表现出相当大的疗效。已经研究了 MNPs 和 MNCs 对致病菌的作用的几种机制,这些机制主要取决于它们的前体类型和处理的细菌。此外,已经对这些纳米材料的抗菌活性进行了许多研究,结果相似也有不同。